Gene constellation of influenza a virus reassortants with high growth phenotype prepared as seed candidates for vaccine production

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Fulvini, Andrew A ^a   Ramanunninair, Manojkumar ^a   Le, Jianhua ^a   Pokorny, Barbara A ^a   Arroyo, Jennifer Minieri ^a   Silverman, Jeanmarie ^a   Devis, Rene ^a   Bucher, Doris ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ;

ANTIGENIC VARIATION; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC CODE; GENETIC REASSORTMENT; GENOME ANALYSIS; HEMAGGLUTINATION TEST; INFLUENZA A; INFLUENZA VACCINATION; INFLUENZA VIRUS A; NONHUMAN; PHENOTYPE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; VACCINE PRODUCTION; VIROGENESIS; VIRUS GENOME; VIRUS HEMAGGLUTINATION; VIRUS TYPING; WILD TYPE; BIOSYNTHESIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; VIRUS GENE;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SPONDIAS PURPUREA;

GENES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REASSORTANT VIRUSES; RESTRICTION MAPPING;

EID: 79958716539     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020823     Document Type: Article

References (32)

1. Francis T Jr, (1944) A clinical evaluation of vaccination against influenza. JAMA 124: 982-985.
2. Francis T Jr, (1945) The development of the 1943 vaccination study of the commission on influenza. Amer J Hygiene 42: 1-11.
3. Palese P, Shaw ML, (2007) Orthomyxoviridae: The Viruses and Their Replication. In: Knipe DM, Howley PM, editors. Fields Virology 5th ed Philadelphia Lippincott Williams & Wilkins Publishing pp. 1647-1689.
4. Kilbourne ED, (1969) Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ 41: 643-645.
5. Kilbourne ED, Murphy JS, (1960) Genetic studies of influenza viruses. I. viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage asian strain isolates by combination with PR8. J Exp Med 111: 387-406.
6. McCahon D, Schild GC, (1972) Segregation of antigenic and biological characteristics during influenza virus recombination. J Gen Virol 15: 73-77.
7. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, et al. (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96: 9345-9350.
8. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, et al. (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73: 9679-9682.
9. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG, (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97: 6108-6113.
10. Hoffmann E, Krauss S, Perez D, Webby R, Webster RG, (2002) Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20: 3165-3170.
11. Neumann G, Fujii K, Kino Y, Kawaoka Y, (2005) An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A 102: 16825-16829.
12. Subbarao K, Chen H, Swayne D, Mingay L, Fodor E, et al. (2003) Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305: 192-200.
13. Webby RJ, Perez DR, Coleman JS, Guan Y, Knight JH, et al. (2004) Responsiveness to a pandemic alert: Use of reverse genetics for rapid development of influenza vaccines. Lancet 363: 1099-1103.
14. Kilbourne ED, Schulman JL, Schild GC, Schloer G, Swanson J, et al. (1971) Related studies of a recombinant influenza-virus vaccine. I. derivation and characterization of virus and vaccine. J Infect Dis 124: 449-462.
15. Leibovitz A, Coultrip RL, Kilbourne ED, Legters LJ, Smith CD, et al. (1971) Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees. J Infect Dis 124: 481-487.
16. Baez M, Palese P, Kilbourne ED, (1980) Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis 141: 362-365.
17. Johansson BE, Bucher DJ, Pokorny BA, Mikhail A, Kilbourne ED, (1989) Identification of PR8 M1 protein in influenza high-yield reassortants by M1-specific monoclonal antibodies. Virology 171: 634-636.
18. Oxford JS, McGeoch DJ, Schild GC, Beare AS, (1978) Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature 273: 778-779.
19. Offringa DP, Tyson-Medlock V, Ye Z, Levandowski RA, (2000) A comprehensive systematic approach to identification of influenza A virus genotype using RT-PCR and RFLP. J Virol Methods 88: 15-24.
20. Rudneva IA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Varich NL, et al. (2007) Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants. Arch Virol 152: 1139-1145.
21. Sakamoto S, Kino Y, Oka T, Herlocher ML, Maassab HF, (1996) Gene analysis of reassortant influenza virus by RT-PCR followed by restriction enzyme digestion. J Virol Methods 56: 161-171.
22. Brett I, Werber J, Kilbourne ED, (2002) Rapid confirmation by RFLP of transfer to vaccine candidate reassortment viruses of the principal 'high yield' gene of influenza A viruses. J Virol Methods 100: 133-140.
23. Osterhaus AD, Poland GA, (2008) Vaccines against seasonal and avian influenza: Recent advances. Vaccine 26 (Suppl 4): D1-2.
24. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, et al. (1990) Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175: 59-68.
25. Robertson JS, Nicolson C, Harvey R, Johnson R, Major D, et al. (2011) The development of vaccine viruses against pandemic A (H1N1) influenza. Vaccine 29: 1836-1843.
26. Kilbourne ED, (1978) Genetic dimorphism in influenza viruses: Characterization of stably associated hemagglutinin mutants differing in antigenicity and biological properties. Proc Natl Acad Sci U S A 75: 6258-6262.
27. Both GW, Shi CH, Kilbourne ED, (1983) Hemagglutinin of swine influenza virus: A single amino acid change pleiotropically affects viral antigenicity and replication. Proc Natl Acad Sci U S A 80: 6996-7000.
28. Kilbourne ED, Taylor AH, Whitaker CW, Sahai R, Caton AJ, (1988) Hemagglutinin polymorphism as the basis for low- and high-yield phenotypes of swine influenza virus. Proc Natl Acad Sci U S A 85: 7782-7785.
29. Pappas C, Aguilar PV, Basler CF, Solorzano A, Zeng H, et al. (2008) Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci U S A 105: 3064-3069.
30. Klimov A, Ghendon Y, Zavadova H, Broucek J, Medvedeva T, (1983) High reproduction capacity of recombinants between H3N2 human influenza and fowl plague viruses is due to the gene coding for M proteins. Acta Virol 27: 434-438.
31. Liu T, Muller J, Ye Z, (2002) Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology. Virology 304: 89-96.
32. World Health Organization Department of Communicable Disease Surveillance and Response (2002) WHO manual on animal influenza diagnosis and surveillance. WHO/CDS/CSR/NCS/2002.5, rev. 1 Geneva, Switzerland World Health Organization pp. 32-33.